Oct 24, 2023 7:00am EDT NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
Oct 17, 2023 9:20am EDT NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Jul 27, 2023 7:00am EDT NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
